RxDoctor Payments Data

Paul Aanderud, DO

Dermatology · Clackamas, ORNPI 1255569273

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,360 of the $3,818 with a category attached, or 88.0%. It is spread thinly across 20 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,536 and has fallen 60.6% since, to $605 in 2025.

$3,818in general payments, 2019–2025

Across 189 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$896
  • Johnson & Johnson$670
  • Lilly USA, LLC$531
  • Regeneron Healthcare Solutions, Inc.$311
  • Novartis$240
  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$211
  • plus $959 from 14 others

What the payments were for

  • Food & beverage$3,36088%
  • Education$45812%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,818 in reported general payments places this provider in the 70th percentile of 175 dermatology providers in Oregon.

See all dermatology providers in Oregon

Medicare billing

Part B allowed, 2024
$216,147
Medicare patients
861
Services billed
3,824

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa21$434,090
Humira(Cf) PenAdalimumab21$216,008
Cosentyx Unoready PenSecukinumab26$205,911
ErivedgeVismodegib14$121,959
Betamethasone Dipropionate295$11,499
Clobetasol Propionate102$3,380
Triamcinolone Acetonide283$2,869
Metronidazole26$1,604
Tacrolimus17$1,513
Doxycycline Hyclate130$1,449
Fluorouracil22$1,303
Doxycycline Monohydrate51$909
Spironolactone61$900
Minoxidil120$827
Econazole Nitrate21$756

Paid to pharmacies, not to this prescriber.

Other dermatology in Clackamas

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →